Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseNovel targets for interleukin 18 binding proteinSoluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptorAssociation of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptorSynthesis and characterization of a thermally-responsive tumor necrosis factor antagonistSerum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional statesPolymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.Regulation of serum amyloid A protein expression during the acute-phase responseMolecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factorEffect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.Proteinase 3 is an IL-32 binding proteinCloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis.Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein.A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.Requirements for leukocyte adhesion molecules in nephrotoxic nephritis.Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.Historical insights into cytokinesSite-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein.How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-kappaB activation by members of the TNF/NGF receptor family.IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.Biphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokine/chemokine protein array analysis.Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice.Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss.Analysis of apoptosis during hair follicle regression (catagen)Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis.Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysisTumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptorProgressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.
P2860
Q21093232-B4858FAC-83BC-435B-A080-F0D65FE0EA7CQ24292449-E3898776-6D6A-43C1-BABD-4830711498ACQ24304040-8BDA8630-7138-4D30-B96D-06DDCAB8A199Q24528198-75CD680D-429F-4B30-B086-AE9835E519DAQ24656182-FBF4C292-EE06-4940-A579-68695A807C66Q24681600-044A45E6-4900-49BD-9596-42E0208423FCQ24812785-4ED9CAD3-F050-48E0-927C-F1580330B8C0Q28281545-5053CFB2-7A34-4309-95CC-8C96014093A7Q28512161-47E99A18-7D08-45E5-ADB6-8F08EDA78214Q30443950-9192DC72-7C1E-4E31-B307-6999C63E211BQ33234335-855E7F65-74EA-49D4-8188-80CD1C781EDEQ33336314-8A4201DB-4FF8-47CC-81BE-28D44E66D5CEQ33438433-BE0D68B3-665A-47A8-8477-5E52D1880489Q33673534-AC4C89C4-67A6-4290-9C6A-8330429E2066Q33739657-15D37C6E-37FB-4584-9C23-023CE7287BB8Q33810622-9484E49C-8927-420F-9FC1-B87EBA46601AQ33864621-70C63CCB-6D66-4398-8FE1-EC12D4078875Q33890510-3B140EA5-BBB2-4DD4-995C-2E98D9FED8ABQ33891111-6B47400B-53FF-4C72-99B3-B75F7D3D487DQ33937497-2CBE4A11-78DE-4348-9401-EF720EA80BC7Q33976177-652D72D9-E482-4C2C-B619-E729F58A8F17Q34071322-2D331582-4B70-4122-B16B-FBCAC09F4DC9Q34140551-1E859C6E-2FBF-45B7-AC11-69F0881F6042Q34409484-3536E1CC-1356-4C1B-AEBD-43C4E8A8A16FQ34708047-9F919FAF-FD0D-481A-BEDF-EBE965391460Q34724669-4441F1C4-7DE5-43ED-8735-FAE8218FD134Q34731204-981996A3-7BCB-4D93-B0BF-980AE3FA97AAQ34976406-77C3E076-47BE-46F9-9832-F9043C43FEC8Q35149088-E51405E6-E22A-47BB-8320-37CA84971C07Q35381050-913D9550-DCD9-4C00-85A0-6CC9D0DD1FFEQ35534763-66786D16-CA3B-459C-9AD5-9CDC3637C07AQ35704561-95540902-CFBA-4560-A06F-1BD467C8C7E1Q35764942-C0765889-166B-42B1-B12B-E2D08D82767CQ35777068-AB937FA8-82AA-48BC-A1C4-A15F09BB2C6AQ35821863-013344D0-B526-495F-9FFD-0A807BFFD51FQ35923285-E8044FFC-90B0-46A5-A48B-229727A1B1BBQ36080342-1A4E9750-7BA4-4378-AEC4-C651E467491FQ36135454-71918B1F-DF88-427B-87B1-C24ACFD36C43Q36230900-EB358848-2FE9-41F3-BC61-FCCCC1109B7BQ36266899-02FDDEA3-A22E-4F43-BA86-F91AF31E59CE
P2860
Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@ast
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@en
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@nl
type
label
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@ast
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@en
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@nl
prefLabel
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@ast
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@en
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@nl
P2093
P1476
Two tumor necrosis factor-bind ...... mor necrosis factor receptors.
@en
P2093
P304
P407
P577
1990-01-01T00:00:00Z